3,135
Views
10
CrossRef citations to date
0
Altmetric
Capacity Building

ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the Americas

ORCID Icon, , ORCID Icon, , ORCID Icon, , , , , , , , , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, , ORCID Icon, , , , , , , , , , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , , , ORCID Icon, , , ORCID Icon & show all
Article: 1666566 | Received 18 Apr 2019, Accepted 23 Aug 2019, Published online: 23 Oct 2019

Figures & data

Table 1. Overview of work packages and their short and long-term impact.

Figure 1. Microcephaly Epidemic Research Group (MERG), Neuro-Zika, and the clinical sites of the Butantan Phase 3 trial for dengue vaccine.

Figure 1. Microcephaly Epidemic Research Group (MERG), Neuro-Zika, and the clinical sites of the Butantan Phase 3 trial for dengue vaccine.

Figure 2. Birth defect surveillance network (RELAMC).

Figure 2. Birth defect surveillance network (RELAMC).

Figure 3. Neuro Emerging Viruses in the Americas Study (NEAS).

Figure 3. Neuro Emerging Viruses in the Americas Study (NEAS).

Table 2. Scientific publications by the Microcephaly Epidemic Research Group (MERG) in North-East Brazil and ZikaPLAN Work Package 1 Partners, from 2015 to present.

Table 3. Web-based information that ZikaPLAN has made publicly available.